CHRISTINA CHIOFALO: Open Payments
NPI 1396437802 · LINDENHURST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $27 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $152 |
| TG Therapeutics, Inc. | 1 | $147 |
| Novo Nordisk Inc | 2 | $135 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $119 |
| Corcept Therapeutics | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
Products named: BRIUMVI, ULTOMIRIS, TEZSPIRE, Ozempic, Korlym, UBRELVY, NP Thyroid 60, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
